Atlas Trials

Assess Urine Biomarkers to Predict Nephropathy in Fabry Disease

Clinical trial NCT06065605 · UNKNOWN

Trial details

NCT number
NCT06065605
Sponsor
Lysosomal and Rare Disorders Research and Treatment Center, Inc.
Status
UNKNOWN
Study type
OBSERVATIONAL
Fabry Disease
Start date
2023-09-14
Primary completion
2025-07-12
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.